Survival outcomes support the benefits of a geriatric assessment for patients age 70 and older with blood cancers who are candidates for hematopoietic stem cell transplants (HSCT).
Medscape Medical News
Survival outcomes support the benefits of a geriatric assessment for patients age 70 and older with blood cancers who are candidates for hematopoietic stem cell transplants (HSCT).
Medscape Medical News
